Sort by
Refine Your Search
-
growing division in a department known for clinical, research, and educational excellence. The Chief of Neuroradiology will oversee imaging throughout the CUIMC/NYP system and provide vision and leadership
-
imaging physics support for ionizing radiation modalities in Radiology. In this role, the AMP will assist the team of seven medical physicists in the routine clinical quality assurance, acceptance testing
-
at Columbia University Irving Medical Center/NewYork-Presbyterian is seeking a full-time, fellowship-trained, cardiothoracic radiologist to join our growing Division of Cardiothoracic Imaging. Join a dynamic
-
, usually on a 7 day-on/14 day-off schedule. The position is a fully remote. The Division of Emergency Radiology oversees all aspects of diagnostic imaging for emergency department patients. We value our
-
in multi-modality medical imaging and adaptive radiotherapy. The Postdoctoral Research Scientist will join a dynamic team of data scientists and clinicians and participate in unique opportunities
-
are currently seeking a staff associate to join our research effort in the CNS tissue-based profiling. We are deploying cutting-edge spatial transcriptomic technologies coupled to a robust image capture and semi
-
one of the world’s most dynamic cities. A lab within the Institute is seeking an Associate Research Scientist who will use mouse virtual reality and in vivo functional imaging to study efficient memory
-
, including reviewing and uploading outside medical records, imaging, radiology reports, and operative notes. Ensure all relevant clinical information is obtained and reviewed prior to the patient?s visit
-
imaging and electrophysiology in awake behaving mice to analyze neural structure and activity patterns, as well as cellular and molecular characterization of engrafted hiPSC-derived neurons. Successful
-
mouse models of psychiatric disorders using advanced molecular, cellular and brain imaging methods with the ultimate goal to facilitate translational efforts and develop new targeted treatments